Search
for
Sort by
Research 331–360 of 1000+
- Tufts of “doll's hair” within a shiny, scarring alopecia
- Update to acne vulgaris treatment for Canadian practice
- Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: A survey-based study
- Steroid-sparing effect of mycophenolate mofetil in the treatment of a subepidermal blistering autoimmune disease in a dog : clinical communication
- Abstracts from the 4th Annual Student Medical Summit
- Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis
- Dermoscopy and Ultraviolet-Enhanced Fluorescence Dermoscopy (UEFD) Increase the Accuracy of Diagnosis and Are Useful in Assessing the Effectiveness of Kerion celsi Treatment
- Evaluation of Serum Ferritin, Creatinine and Liver Enzymes in Patients with ß- thalassemia After Administration of Deferasirox
- FORMULATION AND EVALUATION OF FINASTERIDE SUSTAINED-RELEASE MATRIX TABLETS USING DIFFERENT RATE CONTROLLING POLYMERS
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Fe de errores
- Multiple, hereditary dome-shaped papules and acrochordons. Birt-Hogg-Dube syndrome
- Versatile Use of Submental Tissue for Reconstruction of Perioral Soft Tissue Defects
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Adolescent acne: association to sex, puberty, testosterone and dihydrotestosterone
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Color dilution alopecia in a Yorkshire
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Extensive scleredema adultorum with loss of eccrine glands
- A Soy-Derived Immunostimulating Peptide Inhibits Etoposide-Induced Alopecia in Neonatal Rats
- Dermatological aspects of synthetic cannabinoid addiction
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Tinea Capitis In Adolescent: A Case Report
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Proceedings of the RAMI Intern Section Meeting, 18th January 2014
- Treatment of Scleroderma-Related Microstomia Using Hyaluronic Acid: An Interventional Study
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- LUPUS VASCULITIS